Healthcare research capacity in the GCC: define the gap before choosing support

1. Turn a broad concern into an answerable question

Name the population, setting, service decision and evidence needed. “We need more publications” does not identify whether the missing resource is protected staff time, methodological advice, access to records or an appropriate publication route. Ask what a clinician, patient representative or service manager would do differently if the proposed research answered its question.

Keep an evidence gap separate from a capacity gap. The first concerns what is known about a question; the second concerns the team’s ability to do particular work. A literature search that finds little locally relevant evidence can motivate further investigation, but its conclusion depends on databases, dates, languages and eligibility decisions. An unsuccessful search alone does not establish that no study exists.

Write the initial claim narrowly: “Our team has not yet established whether its referral records can support this outcome.” That statement can guide a concrete check. It does not rank the institution, explain a country’s research output or describe every GCC health system.

2. Use national priorities as context, with their scope intact

The examples below come from three national institutions. They show different policy responsibilities and ambitions; they are not a census of the six GCC countries or evidence that a particular program has achieved its goals. A broad thematic match does not establish funding eligibility, institutional approval or endorsement of a study or publisher.

Reference: Saudi RDIA: Health and Wellness national priority · Qatar QRDI: strategic focus and health priority · Oman Ministry of Health: National Center for Health Research

On small screens, scroll the table horizontally, or focus it and use the arrow keys.

3. Find the dependency that stops the next useful step

WHO’s Eastern Mediterranean operational plan for 2025–2028 includes work on research capacity and the use of evidence in decisions. Its regional scope is broader than the GCC, and planned activities are not measured national outcomes. Use that context to consider the whole route from a useful question to evidence that someone can assess.

Map that route in your own institution. A writing workshop may help a team report completed work, but it cannot supply unavailable measurements. A statistical consultation can expose an infeasible outcome before analysis begins. Support works best when its deliverable matches the dependency actually missing.

Reference: WHO Eastern Mediterranean: strategic operational plan 2025–2028

On small screens, scroll the table horizontally, or focus it and use the arrow keys.

4. Keep permission, feasibility and scientific review separate

Ask the responsible institution to determine the applicable research review, access and sharing requirements before using records. Record what was approved, by whom, for which material and purpose, and any conditions. Access to a system in a clinical role does not by itself answer whether a proposed research use is permitted. This guide does not determine local legal or ethics requirements.

A synthetic rehearsal can test column names, code behavior or a planned handoff while real access remains pending. Label its inputs and outputs clearly. It does not establish real completeness, study feasibility or approval. Similarly, a polished manuscript does not validate an analysis, and acceptance by a journal does not replace the responsibilities of investigators and their institution.

Plan contributions early. Identify who understands the service, who stewards the records, who reviews the methods and who can check the Arabic and English reporting. Agree how substantive contributions and responsibilities will be documented, without selling authorship or assuming that language assistance makes someone an investigator.

5. Worked example: two referral datasets that cannot yet be pooled

This entire project is invented. Two fictional hospitals want to study the interval from referral creation to the first attended specialist visit. Only synthetic field descriptions have been reviewed; real access and required research approvals remain pending. No patient data have been inspected and no outcome has been calculated.

On small screens, scroll the table horizontally, or focus it and use the arrow keys.

6. Buy or arrange support against a defined deliverable

For the fictional project, the first deliverable is a feasibility note: an agreed event definition, a field map, the access decision or its pending status, and a methods reviewer’s assessment. It is not an accepted article. Set a review meeting to decide what can proceed, what needs more information and what should stop.

For each support activity, name the person supplying it and the person accepting the output. Include the source files and explanation the research team needs after the consultant or colleague leaves. When a timeline depends on access, recruitment or editorial decisions, state that dependency instead of promising a publication date.

A publisher can explain its scope and submission requirements; investigators still need to choose a journal suited to the completed work. Keep editorial selection separate from paid support. A regional topic deserves a clear account of its context and limits, without overstating national representativeness to appear more widely relevant.

7. Measure progress at the stage actually reached

DORA advises against using journal-level metrics as substitutes for assessing individual research contributions. For a capacity program, examine the work as well as the count: whether questions became clearer, analyses can be checked and reporting preserves limitations. A journal’s name or metric does not answer those questions.

If you report project numbers, specify the cohort, date and stage. Projects registered for support, protocols reviewed, analyses completed, manuscripts submitted and papers accepted are different counts. Give each count its relevant denominator, and keep pending or unavailable outcomes explicit. Do not add the stages together as though they were different projects.

Evidence of use needs its own record. A paper sent to a service committee is not proof that practice changed; a recorded policy decision is not proof that patient outcomes improved. Define the further assessment needed before making an impact claim. This guide supplies no regional baseline or performance estimate.

Reference: DORA: San Francisco Declaration on Research Assessment

8. Use a one-page capacity worksheet

Complete this sheet with the people who own the question, records and next decision. Keep unresolved items visible. Review the sheet when a dependency changes, preserving the earlier version so that an approved plan is not confused with work already completed.

On small screens, scroll the table horizontally, or focus it and use the arrow keys.

Questions for a practical final check

• The gap is defined locally without an unsupported GCC-wide generalization.
• Policy ambition is distinguished from eligibility and achieved outcomes.
• Access decisions, synthetic rehearsals and scientific review remain separate.
• Support has a concrete deliverable and a responsible reviewer.
• Stage counts and claims about use retain their denominators and limits.